Article
Cardioprotective effects of Glucagon-like Peptide 1 (GLP-1) and their mechanisms
2017-01-01
Abstract excerpt
Background: Glucagon-like Peptide 1 (GLP-1) is a human incretin hormone that has been demonstrated to protect against non-lethal ischaemia reperfusion injury in the left ventricle in humans. It has been suggested from some animal research that this protection may be mediated through the pathway of ischaemic conditioning, of which the opening of the mKATP channel is a key step. Furthermore, it is uncertain whether...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cbacc967-35a3-51e4-b4a1-4ad8c50bcdb2
- DOI
- 10.17863/cam.8511
